semaglutide biosimilar New Dosage Forms Approved by FDA Semaglutide Biosimilar and Generic Market

2 As stated in the announcement, existing patients will have the opportunity to transition to FDA-approved alternatives when clinically appropriate in consultation with a healthcare professional. 1 This shift follows significant regulatory pressure and legal tension

More Ozempic Lawsuit NAION Lawsuit Updates January 15, 2026 Update: The U.S

This may be unavoidable

According to the International Diabetes Federation (IDF), about 537 million people worldwide have diabetes, with 90% being T2D

The TRIUMPH phase 3 trials, which concluded their primary endpoint in December 2025, demonstrated that Retatrutide could help patients lose nearly a third of their body weight

As for heart disease risk markers: triglycerides dropped 37%, waist circumference shrank about 7.5 inches, blood pressure and inflammation markers (hsCRP) also improved